Skip to main content
. 2020 Jan 13;5(4):459–467. doi: 10.1016/j.ekir.2020.01.001

Figure 4.

Figure 4

(a) Research and Development (RAND) Corporation 36-Item Short Form Health Survey (SF-36) quality-of-life individual domain scores for recipients of hepatitis C virus (HCV)−viremic kidneys at baseline and 6 months post-transplantation (n = 7). Quality of life was assessed using the SF-36 at the screening and week 12 sustained virologic response (SVR12) visits. Recipient 3, who had renal vein thrombosis and underwent retransplantation, is not represented here. (b) SF-36 quality of life summary scores for recipients of HCV-viremic kidneys at baseline and 6 months post-transplantation (n = 7). Quality of life was assessed using the SF-36 at the screening and week 12 sustained virologic response (SVR12) visits. The SF-36 summary scores are calculated based on the 8 physical and mental domains. Recipient 3, who had renal vein thrombosis and underwent retransplantation, is not represented here.